These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1310 related items for PubMed ID: 32650743

  • 21. The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity score matching analysis.
    Huang K, Qian T, Chen W, Lao M, Li H, Lin WC, Chen BW, Bai X, Gao S, Ma T, Liang T.
    BMC Cancer; 2024 May 22; 24(1):620. PubMed ID: 38773564
    [Abstract] [Full Text] [Related]

  • 22. Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysis.
    Wang L, Ke Q, Lin N, Zeng Y, Liu J.
    Scand J Gastroenterol; 2019 May 22; 54(5):528-537. PubMed ID: 31081401
    [Abstract] [Full Text] [Related]

  • 23. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
    Peng Z, Chen S, Xiao H, Wang Y, Li J, Mei J, Chen Z, Zhou Q, Feng S, Chen M, Qian G, Peng S, Kuang M.
    Radiology; 2019 Jul 22; 292(1):237-247. PubMed ID: 31135299
    [Abstract] [Full Text] [Related]

  • 24. Aggressive intrahepatic therapies for synchronous hepatocellular carcinoma with pulmonary metastasis.
    Hu Z, Huang P, Zhou Z, Li W, Xu J, Xu K, Wang J, Zhang H.
    Clin Transl Oncol; 2018 Jun 22; 20(6):729-739. PubMed ID: 29110217
    [Abstract] [Full Text] [Related]

  • 25. Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China.
    Wu Z, Cui L, Qian J, Luo L, Tu S, Cheng F, Yuan L, Zhang W, Lin W, Tang H, Li X, Li H, Zhang Y, Zhu J, Li Y, Xiong Y, Hu Z, Peng P, He Y, Liu L, He K, Shen W.
    BMC Cancer; 2023 Apr 07; 23(1):325. PubMed ID: 37029339
    [Abstract] [Full Text] [Related]

  • 26. Serum gamma-glutamyl transferase levels affect the prognosis of patients with intrahepatic cholangiocarcinoma who receive postoperative adjuvant transcatheter arterial chemoembolization: A propensity score matching study.
    Lu Z, Liu S, Yi Y, Ni X, Wang J, Huang J, Fu Y, Cao Y, Zhou J, Fan J, Qiu S.
    Int J Surg; 2017 Jan 07; 37():24-28. PubMed ID: 27756646
    [Abstract] [Full Text] [Related]

  • 27. Transarterial chemoembolization combined with apatinib versus transarterial chemoembolization alone for hepatocellular carcinoma with macroscopic vascular invasion: A propensity score matching analysis.
    Shen L, Chen S, Qiu Z, Qi H, Yuan H, Cao F, Xie L, Chen Q, Li W, Fan W.
    J Cancer Res Ther; 2020 Sep 07; 16(5):1063-1068. PubMed ID: 33004748
    [Abstract] [Full Text] [Related]

  • 28. Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization.
    Gu J, Zhang X, Cui R, Zhang J, Wang Z, Jia Y, Miao R, Dong Y, Ma X, Fan H, Wang H, Ren L, Li Y, Niu W, Zhang J, Qu K, Liu C.
    Eur J Gastroenterol Hepatol; 2019 Jul 07; 31(7):836-844. PubMed ID: 30614882
    [Abstract] [Full Text] [Related]

  • 29. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
    Chen ZH, Zhang XP, Zhou TF, Wang K, Wang H, Chai ZT, Shi J, Guo WX, Cheng SQ.
    Eur J Surg Oncol; 2019 Nov 07; 45(11):2188-2196. PubMed ID: 31256949
    [Abstract] [Full Text] [Related]

  • 30. Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Zhou PY, Tang Z, Liu WR, Tian MX, Jin L, Jiang XF, Wang H, Tao CY, Ding ZB, Peng YF, Qiu SJ, Dai Z, Zhou J, Fan J, Shi YH.
    BMC Cancer; 2017 Nov 14; 17(1):762. PubMed ID: 29137600
    [Abstract] [Full Text] [Related]

  • 31. Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion.
    Sun JJ, Wang K, Zhang CZ, Guo WX, Shi J, Cong WM, Wu MC, Lau WY, Cheng SQ.
    Ann Surg Oncol; 2016 Apr 14; 23(4):1344-51. PubMed ID: 26714945
    [Abstract] [Full Text] [Related]

  • 32. Hepatic resection versus transarterial chemoembolization in infiltrative hepatocellular carcinoma: A multicenter study.
    Wang Y, Shen J, Feng S, Liang R, Lai J, Li D, Peng B, Wang Z, Huang C, Kuang M.
    J Gastroenterol Hepatol; 2020 Dec 14; 35(12):2220-2228. PubMed ID: 32246889
    [Abstract] [Full Text] [Related]

  • 33. Response evaluation of locoregional therapies in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma versus hepatocellular carcinoma: a propensity score matched study.
    Mukund A, V Srinivasan S, Rana S, Vijayaraghavan R, Patidar Y, Arora V, Jindal A, Choudhury A, Shasthry SM, Sarin SK.
    Clin Radiol; 2022 Feb 14; 77(2):121-129. PubMed ID: 34789395
    [Abstract] [Full Text] [Related]

  • 34. Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: Development of a prognostic nomogram.
    Ge Y, Jeong S, Luo GJ, Ren YB, Zhang BH, Zhang YJ, Shen F, Cheng QB, Sui CJ, Wang HY, Xia Q, Chen L.
    Hepatobiliary Pancreat Dis Int; 2020 Apr 14; 19(2):138-146. PubMed ID: 32139295
    [Abstract] [Full Text] [Related]

  • 35. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience.
    Yamamoto Y, Ikoma H, Morimura R, Konishi H, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, Kubota T, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Ochiai T, Otsuji E.
    Anticancer Res; 2013 Nov 14; 33(11):5097-105. PubMed ID: 24222155
    [Abstract] [Full Text] [Related]

  • 36. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
    Li X, Chen B, An C, Cheng Z, Han Z, Liu F, Yu J, Liang P.
    J Cancer Res Ther; 2020 Sep 14; 16(5):1027-1037. PubMed ID: 33004744
    [Abstract] [Full Text] [Related]

  • 37. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
    Kuo MJ, Mo LR, Chen CL.
    BMC Cancer; 2021 Mar 08; 21(1):250. PubMed ID: 33685409
    [Abstract] [Full Text] [Related]

  • 38. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
    Lin CW, Chen YS, Lo GH, Hsu YC, Hsu CC, Wu TC, Yeh JH, Hsiao P, Hsieh PM, Lin HY, Shu CW, Hung CM.
    BMC Gastroenterol; 2020 Apr 10; 20(1):99. PubMed ID: 32272898
    [Abstract] [Full Text] [Related]

  • 39. Quality of life and survival analysis of patients undergoing transarterial chemoembolization for primary hepatic malignancies: a prospective cohort study.
    Eltawil KM, Berry R, Abdolell M, Molinari M.
    HPB (Oxford); 2012 May 10; 14(5):341-50. PubMed ID: 22487072
    [Abstract] [Full Text] [Related]

  • 40. Chemoembolization of recurrent hepatoma after curative resection: prognostic factors.
    Zu QQ, Liu S, Zhou CG, Yang ZQ, Xia JG, Zhao LB, Shi HB.
    AJR Am J Roentgenol; 2015 Jun 10; 204(6):1322-8. PubMed ID: 26001244
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 66.